The incolation of AstraZeneca’s coronavirus vaccine is increasingly controversial. Spain joined on Monday the increasingly long list of countries that have discontinued the use of it after the cases of thrombosis observed in some people who had received this vaccine.
In the Spanish case, the duration of the suspension is, in principle, two weeks, until the pharmacovigilance evaluation committee of the European Medicines Agency (EMA) Investigate these alarming thrombosis cases.
Just yesterday, the news about the investigation being carried out by the Spanish health authorities to clarify the death of a 43-year-old teacher from Marbella, 15 days after receiving the first dose of the vaccine. The teacher died from a massive hemorrhage in her head that the doctors tried to drain with a surgical intervention in which an edema (fluid in the brain) appeared.
Suspension by various countries
As can be seen in the upper map, prepared by StatistaSeveral countries, especially European, have suspended the administration of the vaccine. The first to do so was Denmark, which reported last Thursday that it had stopped inoculating it for 14 days as a precautionary measure.. This was joined on Thursday by Norway and Iceland, which also paused the use of the vaccine.
On Monday several countries joined the brake on the supply of it: the German Health Minister assured that the country was stopping the administration of the antidote in a “preventive” manner, while French President Emmanuel Macron said that they were suspending its use until the European health regulator issued its opinion. For its part, Italy’s drug agency also banned it “temporarily.”
After the announcement by these three countries, Spain also joined. The suspension of the third vaccine approved in the European Union It will possibly affect the vaccination schedule, although in the Spanish case, this delay does not affect the most vulnerable sectors, which are receiving the vaccines from Pfizer and Moderna.
Confidence in vaccination broken?
One of the most authoritative voices in the research of vaccines in our country, Dr. Federico Martinón-Torres, called for calm in an interview on ABC after the brake on the dispensing of the vaccine: «I am concerned about the doubts that may arise in those convinced that getting vaccinated is the right thing to do, “he said.
In fact, the suspension that has been carried out in many European countries, although they are temporary and as a precautionary measure, in addition to being a new setback for the immunization campaign against the coronavirus, only increase the problems of indecision about the vaccines that citizens already had in different degrees.
Although this is not a new phenomenon, the availability of various vaccines has led to some being considered more favorable than others. Before the crisis with the AstraZeneca vaccine, the prestigious British polling firm YouGov showed in a survey carried out from February 23 to March 2, that Europeans already were more likely to choose the Moderna or Pfizer vaccine, in front of the antidote elaborated by the British pharmacist.
In the graphic above, prepared by StatistaIn Spain, almost six out of ten respondents (59%) believed that the British AstraZeneca vaccine was safe, although the Moderna (67%) and Pfizer-BioNTech (72%) antidotes were more trusted. Other European countries such as France and Germany showed less confidence in the British vaccine: only 33% and 43% respectively believed in this antidote as a safe solution against the coronavirus. In the UK, by contrast, AstraZeneca’s vaccine was rated higher than Moderna and Pfizer-BioNtech products in terms of perceived safety.
George is Digismak’s reported cum editor with 13 years of experience in Journalism